The UAE is a strong market for premium supplement brands, but registration rewards brands that arrive organized. The paperwork, the local partner and the Arabic label all need to be ready before you file. Here is what to prepare first so your application does not stall halfway through.
In the US, supplement brands write their own label claims. That freedom is useful, and it is also where most FDA warning letters begin. Here is how we approach structure/function claims so they are clear, persuasive and still standing when someone checks the evidence behind them.
A supplement label that is perfect in one country can be non-compliant in the next. Australia, the US and the UAE each expect different panels, statements and wording. Here is a plain comparison of what each market asks for, so you can plan your packaging before it goes to print.
A small clinical study on your own product can be a powerful marketing asset. It can also be a quiet liability if it is designed poorly or stretched to support claims it never tested. Here is what a modest trial can genuinely prove, and where founders tend to overreach.
A collagen product lives or dies on its dose. Too low and your claims have nothing behind them. Too high and the format becomes a pill count nobody will take. Here is how we think about setting a collagen dose that reads well on the pack and stands up to scrutiny.
One formula for two markets sounds efficient, and it can be. But Australia and the US regulate supplements in very different ways, and the gaps show up in ingredients, doses, claims and labels. Here is how to design a product that travels without a costly rebuild halfway through.
Most supplement founders in Australia assume their product will be listed. Many are right, but the claims you want to make, the ingredients you choose and the dose you land on can push a product into a slower, costlier pathway. Here is how to know where you stand before you formulate.
